Paolo Botti
CHIEF SCIENTIFIC OFFICER
R&D
ArisGen
Switzerland
Biography
Paolo founded ArisGen in 2006 based upon work undertaken in his academic lab. Paolo is a bio-organic chemist who trained at the University of Milan before moving to Vanderbilt University (USA) as a post-doctoral fellow in 1994.In 1999 Paolo became the principal Scientist at Gryphon Therapeutics (USA) developing novel Protein Therapeutics. In 2001 he moved back to Europe as the Director of the (R&D) Protein Synthesis group at Geneprot (Switzerland). Before returning to academia at Unige in 2005. Paolo is an inventor on 14 patents and has published numerous articles in peer reviewed journals.
Research Interest
molecular biology
